These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32255732)

  • 1. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamic DNA methylation landscape of the
    Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
    Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Novel Breast Biospecimen Cell-Type Adjustment Identifies Shared DNA Methylation Alterations in Breast Tissue and Milk with Breast Cancer-Risk Factors.
    Muse ME; Carroll CD; Salas LA; Karagas MR; Christensen BC
    Cancer Epidemiol Biomarkers Prev; 2023 Apr; 32(4):550-560. PubMed ID: 36780234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.
    Ramos EA; Camargo AA; Braun K; Slowik R; Cavalli IJ; Ribeiro EM; Pedrosa Fde O; de Souza EM; Costa FF; Klassen G
    BMC Cancer; 2010 Jan; 10():23. PubMed ID: 20109227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer.
    Tommasi S; Karm DL; Wu X; Yen Y; Pfeifer GP
    Breast Cancer Res; 2009; 11(1):R14. PubMed ID: 19250546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.
    Moelans CB; Verschuur-Maes AH; van Diest PJ
    J Pathol; 2011 Oct; 225(2):222-31. PubMed ID: 21710692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide DNA methylation profiling reveals parity-associated hypermethylation of FOXA1.
    Ghosh S; Gu F; Wang CM; Lin CL; Liu J; Wang H; Ravdin P; Hu Y; Huang TH; Li R
    Breast Cancer Res Treat; 2014 Oct; 147(3):653-9. PubMed ID: 25234841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
    BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.
    Muggerud AA; Rønneberg JA; Wärnberg F; Botling J; Busato F; Jovanovic J; Solvang H; Bukholm I; Børresen-Dale AL; Kristensen VN; Sørlie T; Tost J
    Breast Cancer Res; 2010; 12(1):R3. PubMed ID: 20056007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
    Ramezani F; Salami S; Omrani MD; Maleki D
    Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
    Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
    BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma.
    Kang JH; Kim SJ; Noh DY; Park IA; Choe KJ; Yoo OJ; Kang HS
    Lab Invest; 2001 Apr; 81(4):573-9. PubMed ID: 11304577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.